Attune Pharmaceuticals
http://attunepharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Attune Pharmaceuticals
Kalvista Stops Phase II HAE Prophylactic Trial Following Liver Enzyme Concerns
The US firm’s oral plasma kallikrein inhibitor was associated with liver elevations in a number of Phase II patients, prompting a trial termination and shift in focus to an on-demand program.
Start-Up Execs On The Move, November 2012
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Recent Financings of Private Companies, November 2012
START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.
Medical Device Deals Update, October 2012
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice